The notion that impairment can be assumed or not based solely on specific concentrations of THC or its metabolites in a driver’s blood or urine is plainly wrong.
The American Journal of Endocannabinoid Medicine (AJEM) is the only printed, peer-reviewed, medical cannabis journal in North America. AJEM’s mission is to create, collect, and disseminate credible cannabis research data.
If cannabis stores close, the state of Oregon would be depriving many patients who rely on retail cannabis stores access to their medicine. If retail cannabis stores remain open, does it make sense to limit access to medicinal patents?
Trademark registration is not simply a matter of racing to the USPTO to register a word or phrase that you wish to have exclusive rights to, even if you were the first to use the word or phrase.
As a service to our current clients and readers during these difficult times, we are offering a free 20-minute phone call to address your pressing issues – no strings attached.
For my talk, I compared and contrasted the hemp and CBD regulatory regimes in Europe and US. Although they parallel each other in some respects, particularly policy, they are fundamentally different in their approaches.
The FDA has yet to create a regulatory pathway for CBD. Does its most recent report to Congress herald a change?
Although the DOT Notice regarding drug testing purports to clarify the law with respect to a certain category of “safety-sensitive” employees, it really just muddies the water.
This second installment of a two-part series discusses important things to know when stopped in public by law enforcement while transporting hemp or a hemp-derived product.
This first installment of a two-part series covers important things to know in general about being stopped in public by law enforcement while in possession of hemp or a hemp-derived product.